BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37370103)

  • 21. Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests.
    Kukuk GM; Schaefer SG; Fimmers R; Hadizadeh DR; Ezziddin S; Spengler U; Schild HH; Willinek WA
    Eur Radiol; 2014 Oct; 24(10):2482-90. PubMed ID: 25030459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting post-hepatectomy liver failure by combined volumetric, functional MR image and laboratory analysis.
    Chuang YH; Ou HY; Lazo MZ; Chen CL; Chen MH; Weng CC; Cheng YF
    Liver Int; 2018 May; 38(5):868-874. PubMed ID: 28987012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The technique of 3D reconstruction combining with biochemistry to build an equivalent formula of indocyanine green (ICG) clearance test to assess the liver reserve function.
    Zheng J; Xie W; Huang Y; Zhu Y; Jiang L
    BMC Surg; 2020 Nov; 20(1):283. PubMed ID: 33183305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness comparison of indocyanine green retention test with the cirrhotic severity scoring in evaluating the pathological severity of liver cirrhosis in patients with hepatocellular carcinoma and Child-Pugh grade A liver function.
    Gu J; Zhang E; Liang B; Zhang Z; Chen X; Huang Z
    World J Surg Oncol; 2020 Apr; 18(1):79. PubMed ID: 32326968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between liver function and liver signal intensity in hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging.
    Tajima T; Takao H; Akai H; Kiryu S; Imamura H; Watanabe Y; Shibahara J; Kokudo N; Akahane M; Ohtomo K
    J Comput Assist Tomogr; 2010; 34(3):362-6. PubMed ID: 20498536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative estimation of future remnant liver function following portal vein embolization using relative enhancement on gadoxetic acid disodium-enhanced magnetic resonance imaging.
    Sato Y; Matsushima S; Inaba Y; Sano T; Yamaura H; Kato M; Shimizu Y; Senda Y; Ishiguchi T
    Korean J Radiol; 2015; 16(3):523-30. PubMed ID: 25995681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-hepatectomy liver failure after major hepatic surgery: not only size matters.
    Asenbaum U; Kaczirek K; Ba-Ssalamah A; Ringl H; Schwarz C; Waneck F; Fitschek F; Loewe C; Nolz R
    Eur Radiol; 2018 Nov; 28(11):4748-4756. PubMed ID: 29767320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Comparative Study of Albumin-Bilirubin Score with Child-Pugh Score, Model for End-Stage Liver Disease Score and Indocyanine Green R15 in Predicting Posthepatectomy Liver Failure for Hepatocellular Carcinoma Patients.
    Zou H; Yang X; Li QL; Zhou QX; Xiong L; Wen Y
    Dig Dis; 2018; 36(3):236-243. PubMed ID: 29495004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between dynamic gadoxetate-enhanced MRI and
    Rassam F; Zhang T; Cieslak KP; Lavini C; Stoker J; Bennink RJ; van Gulik TM; van Vliet LJ; Runge JH; Vos FM
    Eur Radiol; 2019 Sep; 29(9):5063-5072. PubMed ID: 30796575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative analysis of liver function using superparamagnetic iron oxide- and Gd-EOB-DTPA-enhanced MRI: comparison with Technetium-99m galactosyl serum albumin scintigraphy.
    Nishie A; Ushijima Y; Tajima T; Asayama Y; Ishigami K; Kakihara D; Nakayama T; Takayama Y; Okamoto D; Abe K; Obara M; Yoshimitsu K; Honda H
    Eur J Radiol; 2012 Jun; 81(6):1100-4. PubMed ID: 21435811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
    Zhu WS; Shi SY; Yang ZH; Song C; Shen J
    World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative parameters obtained from gadobenate dimeglumine-enhanced MRI at the hepatobiliary phase can predict post-hepatectomy liver failure and overall survival in patients with hepatocellular carcinoma.
    Cai S; Lin X; Sun Y; Lin Z; Wang X; Lin N; Zhao X
    Eur J Radiol; 2022 Sep; 154():110449. PubMed ID: 35901599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver failure after major liver resection: risk assessment by using preoperative Gadoxetic acid-enhanced 3-T MR imaging.
    Wibmer A; Prusa AM; Nolz R; Gruenberger T; Schindl M; Ba-Ssalamah A
    Radiology; 2013 Dec; 269(3):777-86. PubMed ID: 23942606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deep Learning-Based Assessment of Functional Liver Capacity Using Gadoxetic Acid-Enhanced Hepatobiliary Phase MRI.
    Park HJ; Yoon JS; Lee SS; Suk HI; Park B; Sung YS; Hong SB; Ryu H
    Korean J Radiol; 2022 Jul; 23(7):720-731. PubMed ID: 35434977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visualization of liver uptake function using the uptake contrast-enhanced ratio in hepatobiliary phase imaging.
    Matsushima S; Sato Y; Yamaura H; Kato M; Kinosada Y; Era S; Takahashi K; Inaba Y
    Magn Reson Imaging; 2014 Jul; 32(6):654-9. PubMed ID: 24637082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing liver function: diagnostic efficacy of parenchymal enhancement and liver volume ratio of Gd-EOB-DTPA-enhanced MRI study during interstitial and hepatobiliary phase.
    Ippolito D; Pecorelli A; Famularo S; Bernasconi D; Orsini EB; Giani A; Romano F; Talei Franzesi C; Sironi S
    Abdom Radiol (NY); 2019 Apr; 44(4):1340-1349. PubMed ID: 30411177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Image Non-Uniformity Correction for 3-T Gd-EOB-DTPA-Enhanced MR Imaging of the Liver.
    Ogasawara G; Inoue Y; Matsunaga K; Fujii K; Hata H; Takato Y
    Magn Reson Med Sci; 2017 Apr; 16(2):115-122. PubMed ID: 27385553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular carcinoma with indocyanine green excretory defect: a case report and review of the literature.
    Liu W; Chen LJ; Jiang Y; Xu LJ; Qiu X
    J Int Med Res; 2021 Apr; 49(4):3000605211004025. PubMed ID: 33845602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance elastography as a predictor of insufficient liver enhancement on gadoxetic acid-enhanced hepatocyte-phase magnetic resonance imaging in patients with type C hepatitis and Child-Pugh class A disease.
    Motosugi U; Ichikawa T; Muhi A; Sano K; Morisaka H; Ichikawa S; Araki T
    Invest Radiol; 2012 Oct; 47(10):566-70. PubMed ID: 22955025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk Stratification of Patients with Marginal Hepatic Functional Reserve Using the Remnant Hepatocyte Uptake Index in Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for Safe Liver Surgery.
    Akabane M; Shindoh J; Kobayashi Y; Okubo S; Matsumura M; Hashimoto M
    World J Surg; 2023 Apr; 47(4):1042-1048. PubMed ID: 36622435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.